Skyline Medical Becomes Member of Practice Greenhealth, Highlighting Positive Environmental Impact of STREAMWAY® System
MINNEAPOLIS, Oct. 9, 2013 /PRNewswire/ -- Skyline Medical, Inc. (OTCQB: SKLN) (the "Company"), formerly BioDrain Medical, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, has recently joined as a member of Practice Greenhealth, highlighting the positive environmental impact its STREAMWAY System technology will have in hospitals and surgical centers, as well as the health benefits it will bring to patients and personnel.
Practice Greenhealth is the nation's leading health care community that empowers its members to increase their efficiencies and environmental stewardship while improving patient safety and care through tools, best practices and knowledge.
"The mission of Practice Greenhealth aligns perfectly with the goals and benefits of Skyline Medical's STREAMWAY System. Not only is our surgical fluid waste disposal system the safest and easiest to use for personnel, it makes procedures more efficient, which benefits patients. Furthermore, our system is less harmful to the environment than traditional canister disposal methods, which we are quickly replacing throughout the market," said Josh Kornberg, CEO of Skyline Medical.
Kornberg continued, "We look forward to collaborating with companies all over the U.S. who are working toward better safety for patients and more environmentally friendly solutions in the medical space. As we continue to improve the STREAMWAY System technology and as it becomes more widely adopted, we appreciate the opportunity for insights and a forum for discussion with others addressing the same issues — being green, efficient and safe."
The FDA-approved STREAMWAY System is designed to improve safety and efficiency in the operating room by safely and seamlessly managing surgical fluid waste disposal with its direct-to-drain technology. The STREAMWAY System virtually eliminates certain operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment while dramatically decreasing costs to dispose of surgical waste. The STREAMWAY System is designed to be installed into each surgical room and connected directly into a hospital's existing drain and vacuum system.
About Skyline Medical Inc. Skyline Medical Inc. produces a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and is not an optimal approach to the handling of surgical fluid waste. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2)
improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).
Skyline Medical's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of Skyline Medical's STREAMWAY System, the number of canisters can be significantly reduced. Skyline Medical Inc.'s STREAMWAY System is designed to make the operating room and our environment safer, cleaner, and better. Skyline Medical products are currently being represented by independent professional sales
representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.skylinemedical.com.
Forward-looking Statements Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $0.7 million in debts, liabilities and cash obligations that become due over the next twelve months;potential claims for past violations of shareholders' preemptive rights, the amount of which claims is impossible to estimate, as discussed in the Company's Form 10-Q for the quarter ended June 30, 2013;unexpected costs and operating deficits, and lower than expected sales and revenues, if
any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and inability to attract or retain qualified senior management personnel, including sales and marketing personnel;our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and
uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, as amended, and subsequent 8-K and other filings at www.sec.gov.
Public Relations Contact: Samantha Wolf KCSA Strategic Communications 212-896-1220 swolf@kcsa.com
